Sun Pharma Acquires Organon in $11.75 Billion Deal – India’s Biggest Overseas Pharma Buy
Sun Pharma will buy Organon for $11.75B, boosting global reach, women’s health, and specialty drugs, and creating a $12.4B annual revenue pharma giant.
/ 1659 items
#XY↓
Deutsche Bank and Truist Go Bullish on Ascentage Pharma
Ascentage Pharma gets Buy ratings; its cancer drugs show strong results, fast growth in China, and high future upside potential.
Radoff-JEC Group Boosts Seer Takeover Bid to $2.35
Investors offered to buy Seer for $2.35/share plus extra future payout; stock rose after takeover bid. Board responds by May 2.
Lilly’s New Weight-Loss Pill Foundayo Gets Off to a Slow Start
Lilly’s new weight-loss pill started slow, far behind Novo’s, but it’s too early to tell which drug will win.
Indian Pharma Giant Sun Pharma Launches $13 Billion Takeover Bid for Organon
Sun Pharma offers $13B to buy Organon, aiming to expand globally in branded drugs, competing with EQT and Grünenthal.
Oppenheimer Turns Bullish on Savara as Molgramostim Moves Closer to Approval
Savara gets FDA priority review for its drug, analyst raises target to $11, sees strong approval chances and upside.